Amount Raised
$200 Million
Round Type
Post-IPO Equity
CarlsbadBiotechnologyHealth CareTherapeuticsInvestors
Description
Tyra Biosciences, Inc. announced a $200 million private placement financing led by RA Capital Management with participation by new and existing institutional investors, including Boxer Capital, BVF Partners, Nextech Invest Ltd, OrbiMed, 5AM Ventures, a large investment management firm, and a life-sciences focused institutional investor.
Quick answer
Tyra Biosciences raised $200 Million in a Post-IPO Equity round, dated February 2, 2024. Investors: Nextech Invest, Ltd, A Life Sciences Focused Institutional Investor, A Large Investment Management Firm, 5 Am Ventures, Orbi Med, BVF Partners, Boxer Capital and RA Capital Management. Tyra Biosciences is based in Carlsbad, California, United States.
- How much did Tyra Biosciences raise?
- Tyra Biosciences raised $200 Million in a Post-IPO Equity round on February 2, 2024.
- Who invested in Tyra Biosciences?
- Nextech Invest, Ltd, A Life Sciences Focused Institutional Investor, A Large Investment Management Firm, 5 Am Ventures, Orbi Med, BVF Partners, Boxer Capital and RA Capital Management are named as investors in this round.
- What does Tyra Biosciences do?
- Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology.
- Where is Tyra Biosciences based and how big is it?
- Tyra Biosciences is based in Carlsbad, California, United States. Fundz records about 87 employees.
- Who are the decision-makers at Tyra Biosciences?
- Fundz holds 1 contact at Tyra Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Tyra Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Neurogene raised $105M (IPO) on March 18, 2024.
- bluebird bio raised $175M (Debt Financing) on March 18, 2024.
- Aprea Therapeutics raised $34M (Funding Round) on March 18, 2024.
- bluebird bio raised $175M (Debt Financing) on March 18, 2024.
- Tessera Defense & Homeland Security Inc. raised $62M on March 15, 2024.
- Lexeo Therapeutics raised $95M on March 15, 2024.
Who to call at Tyra Biosciences, and when
A new round usually means Tyra Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tyra Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tyra Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tyra Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tyra Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Tyra Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.